A pediatric case of diphthamide biosynthesis 1 gene defect presenting with developmental delay, short stature, dysmorphic features, and sparse hair (Loucks-Innes syndrome): a case report Authors: Yazan A. Al-Ajlouni, Maysa Lihaz, Mohammad Islam Published: 2025 ABSTRACT BackgroundDiphthamide biosynthesis 1 is a critical component of the multiprotein complex responsible for diphthamide biosynthesis. Autosomal recessive variants in Diphthamide biosynthesis 1 gene are associated with an ultra-rare neurodevelopmental disorder called developmental delay with short stature, dysmorphic facial features, and sparse hair, also known as Loucks-Innes syndrome. To the best of our knowledge, there have been fewer than 20 reported cases of Loucks-Innes syndrome in the literature.Case reportWe present a 14-year-old Yemeni male patint with novel homozygous variants in diphthamide biosynthesis 1, who presented with a history of congenital hydrocephalus, neonatal seizures, dysmorphic face, and sparse hair. The patient also had aortic root dilation, intellectual disability, short stature, hypoplastic toenails, and mixed conductive and sensorineural hearing loss in both ears. He was only able to move around by crawling and was confined to a wheelchair.ConclusionThis case report adds to the limited knowledge on developmental delay with short stature, dysmorphic facial features, and sparse hair and highlights the importance of genetic workup in patients with intellectual disability, short stature, and craniofacial and ectodermal anomalies. Further research is needed to better understand the pathogenesis and clinical features of this rare syndrome. Introduction Diphthamide biosynthesis 1 (DPH1), encoded by DPH1 gene, is a critical component of the multiprotein complex responsible for diphthamide biosynthesis. Together with DPH2, DPH3, DPH4, and DPH5, DPH1 carries out the diphthamide modification on eukaryotic elongation factor 2 (EEF2) [3, 7]. This modification is essential for protein synthesis and is found only in eukaryotic and archaeal translation elongation factor 2 (EF2). Furthermore, animal studies have shown that DPH1-null mice experience cell death, embryonic lethality, and growth defects [5]. Furthermore, DPH1 functions as a tumor-suppressor gene, playing a crucial role in regulating cell proliferation, embryonic development, and tumorigenesis [2, 10]. In recent studies, it has been discovered that autosomal recessive variants in DPH1 gene are associated with an ultra-rare neurodevelopmental disorder called developmental delay with short stature, dysmorphic features, and sparse hair (DEDSSH; MIM #616901), which is also known as Loucks-Innes syndrome. This disorder is characterized by several specific clinical features, such as intellectual disability, short stature, and craniofacial and ectodermal anomalies [9]. To the best of our knowledge, there have been fewer than 20 reported cases of Loucks-Innes syndrome in the literature. The pooling of cohorts through published literature led to the establishment of this syndrome. The reported cases of Loucks-Innes syndrome include four patients from Saudi Arabia [1] and four patients from North America [4], as well as two patients each from Pakistan [6], Iran [8], Malta [9], and Yemen [9], and one patient from Japan [5]. In this case report, we present the detailed clinical features of a Yemeni patient with novel homozygous variants in DPH1. Case report History and findings The patient is a 14-year-old male adolescent born in Yemen in 2008 as the second son to a Yemeni family via Cesarean section between 38 and 39 weeks due to polyhydramnios. Although the pregnancy was uneventful, the patient experienced congenital hydrocephalus soon after birth, which led to neonatal intensive care unit (NICU) admission and intubation. Neonatal seizures persisted until he reached 1 year of age. Details regarding his birth, neonatal, and early childhood history are limited due to care received outside the USA. At the age of 5 years, the patient began receiving genetic workup and healthcare in the USA, which continues until this time. At the age of 8 years, he underwent ventriculoperitoneal shunt (VPS) placement due to hydrocephalus. Echocardiogram performed during this period revealed dilated aortic root and ascending aorta, along with mild aortic insufficiency. When examined at the age of 10 years, the patient had a dysmorphic face with macrocephaly and frontal bossing, shunt present on the right side of the body, sunken orbits, mild epicanthal folds, and a whorl on the right side of the face. Additionally, he had hypertelorism and diffuse sparse hair. Other anomalies noted included micropenis, a short-high palate with multiple missing teeth, congenital vertical talus, pectus excavatum, and hypoplastic toenails. Despite exhibiting bowing of legs, the patient was able to stand and walk short distances, though he was nonverbal with poor eye contact. He has been receiving physical, occupational, and speech therapy twice a week for several years and currently continues to attend a special educational school. During development, the patient’s weight and height growth curves were consistently below the fifth percentile, and he experienced repeated respiratory infections that often required hospitalization. Currently, at the age of 14 years, he continues to suffer from severe failure to thrive, gaining less than 2 kg in the past year despite receiving nutritional supplements and consuming soft solids. He currently ranks in the bottom one percentile for height, weight, and body mass index for his age, with his height and weight being consistent with those of a 7-year-old boy. During the most recent examination at age 14 years, the patient had been experiencing difficulty standing up and walking for several months, and was only able to move around by crawling, being currently confined to a wheelchair. Despite occasional finger biting, no self-injurious behavior was noted. The patient was found to have mixed conductive and sensorineural hearing loss in both ears, contributing to poor hearing. He continues to exhibit severe global developmental delay, with a dilated aortic root that is being managed with losartan and atenolol. From a physical medicine and rehabilitation perspective (PM&R), the patient had been using an ankle–foot orthosis (AFO) for ambulation for an extended period; however, the AFO became ill-fitting in the last few months prior to his most recent examination, and the patient has been unable to use it. The patient has been walking indoors with a flexed knee position, possibly due to weakness of the knee muscles. To improve the patient’s gait and physical function and prevent further complications, the patient will be provided with a new AFO that fits properly, physical therapy to strengthen the knee and hip muscles, and gait training. Genetic investigation summary Genetic workup was initiated at the age of 5 years, which included karyotyping, microarray analysis, and whole exome sequencing (WES). In 2012, karyotype analysis revealed a normal male 46, XY genotype. Microarray analysis conducted in the same year showed regions of homozygosity, with the patient’s parents being second cousins. In 2013, WES failed to identify any underlying genetic cause, despite the microarray showing a high degree of loss of heterozygosity, including the DPH1 gene, where a homozygous variant of uncertain significance (VUS) was identified (c.335A > G). Both parents were found to be heterozygous for this variant. In 2020, the VUS in the patient’s DPH1 gene was reclassified as pathogenic, consistent with DEDSSH or Loucks-Innes syndrome, which was also consistent with the patient’s clinical presentation. The phenotypic features observed in the patient were in line with the presentation of this syndrome. Discussion This case report presents a 14-year-old male patient with a homozygous variation in the DPH1 gene (c.335A > G), consistent with Loucks-Innes syndrome. Loucks-Innes syndrome is an ultra-rare and severe neurodevelopmental disorder, with fewer than 20 patients reported in the literature from different ethnicities. To the best of our knowledge, this is the third reported case of Loucks-Innes syndrome with C335A > G mutation at the cDNA level. Previously, Urreizti et al. [9] reported two cases from Yemeni families whose parents are first cousins and were characterized with the C335A > G mutation [9]. The patient’s clinical presentation, including short stature, developmental delay, dysmorphic features, and mixed conductive and sensorineural hearing loss, is consistent with the reported cases of Loucks-Innes syndrome. The syndrome is characterized by a distinct pattern of clinical features, including intellectual disability, short stature, and craniofacial and ectodermal anomalies, such as sparse hair, thin skin, and abnormal nails. This supports the pathogenicity of the DPH1 variant identified in this case. Notably, hearing loss is a less common finding in Loucks-Innes syndrome, which can be sensorineural, conductive, or mixed. While Louckss et al. [4] reported mild hearing loss in an 18-year-old patient, which has been stable, the patient reported in this case has been experiencing severe hearing loss that interferes with daily activities and school attendance [4]. This emphasizes the importance of regular surveillance for hearing loss in patients with Loucks-Innes syndrome, as progressive hearing loss can occur, and it may provide further insight into the pathogenesis of the disorder. Additionally, this case report highlights the important role of PM&R in the care of patients with Loucks-Innes syndrome. In this case, the patient’s ill-fitting AFO led to significant functional limitations and ultimately affected his gait and physical function. By providing a new AFO, physical therapy, and gait training, the PM&R team works on improving the patient’s mobility and preventing further complications. Furthermore, regular follow-up with a rehabilitation physician can help patients manage their symptoms, prevent deterioration of function, and promote overall health and wellness. This underscores the importance of interdisciplinary care for individuals with disabilities and highlights the valuable contribution of PM&R specialists in enhancing their quality of life. This case report contributes to the limited existing knowledge on Loucks-Innes syndrome by presenting a unique and novel finding of homozygous variants in the DPH1 gene. The comprehensive description of the patient’s clinical features, including neurodevelopmental, craniofacial, ectodermal, and cardiovascular abnormalities, provides valuable insights into the diverse manifestations of the syndrome. Furthermore, the inclusion of the patient’s demographic information, such as being born in Yemen, adds a global perspective to the understanding of the syndrome and its potential geographic distribution. Additionally, this report provides a perspective from the field of PM&R, highlighting the function implications of the patient’s condition. However, it is important to acknowledge the limitations of this case report. Firstly, the rarity of Loucks-Innes syndrome and the limited number of reported cases in the literature may restrict the generalizability of findings and hinder the ability to draw definitive conclusions about the syndrome. Additionally, the absence of molecular and functional studies to elucidate the precise mechanisms underlying the pathogenesis of Loucks-Innes syndrome limits the understanding of the disease at a cellular and molecular level. Lastly, as a single case report, there is a possibility of inherent biases and limitations associated with the reporting and interpretation of the patient’s clinical features, potentially impacting the accuracy and completeness of the information presented. The identification of a pathogenic variant in the DPH1 gene in our patient confirms the genetic basis of Loucks-Innes syndrome and highlights the importance of considering this rare disorder in patients presenting with short stature, developmental delay, dysmorphic features, and hearing loss. This knowledge can inform genetic counseling and family planning for the patient and their family, allowing for appropriate testing and informed decision-making regarding future pregnancies. Additionally, DPH1’s essential role in diphthamide biosynthesis and its potential role in other cellular processes and pathways may provide insights into the pathogenesis of Loucks-Innes syndrome and related disorders. Further investigation of the molecular mechanisms underlying this rare disease may lead to the development of targeted therapies and improved clinical management strategies for affected individuals. Conclusion The case of this 14-year-old male patient with Loucks-Innes syndrome highlights the importance of genetic testing in the diagnostic workup of rare neurodevelopmental disorders. The identification of a pathogenic variant in the DPH1 gene in this patient confirms the genetic basis of the disease and can inform genetic counseling and family planning for the patient and their family. The patient’s clinical presentation, including short stature, developmental delay, dysmorphic features, and hearing loss, is consistent with the reported cases of Loucks-Innes syndrome, but the progressive hearing loss observed in this patient warrants further surveillance and investigation. Overall, this case report contributes to the limited knowledge of Loucks-Innes syndrome and provides insights for future research into targeted therapies and clinical management for this ultra-rare and severe disorder.